Loading chat...
HI SR4
Resolution
Status
1/30/2025
Primary Sponsor
Kurt Fevella
Click for details
AI Summary
SR4 Summary
-
Requests the State Auditor to assess the social and financial effects of a proposed mandate requiring health insurance coverage for intravenous ketamine therapy to treat depression
-
Requires the assessment to be conducted pursuant to Hawaii Revised Statutes section 23-51, which mandates auditor review before any health insurance mandate can be considered legislatively
-
Auditor must submit findings, recommendations, and any proposed legislation to the Legislature no later than twenty days before the 2026 Regular Session convenes
-
Certified copies of the resolution must be transmitted to the Auditor and Insurance Commissioner
Legislative Description
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Intravenous Ketamine Therapy To Treat Depression.
Medicaid
Last Action
The committee on HHS deferred the measure.
3/24/2025